Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1978 2
1980 1
1983 2
1987 2
1989 4
1991 2
1992 3
1993 3
1995 6
1996 4
1997 3
1998 6
1999 3
2000 7
2001 4
2002 5
2003 10
2004 7
2005 10
2006 15
2007 18
2008 19
2009 24
2010 27
2011 29
2012 26
2013 38
2014 38
2015 30
2016 38
2017 29
2018 38
2019 57
2020 71
2021 91
2022 10
Text availability
Article attribute
Article type
Publication date

Search Results

575 results
Results by year
Filters applied: . Clear all
Page 1
Sustained Cross-reactive Antibody Responses After Human Papillomavirus Vaccinations: Up to 12 Years Follow-up in the Finnish Maternity Cohort.
Kann H, Lehtinen M, Eriksson T, Surcel HM, Dillner J, Faust H. Kann H, et al. J Infect Dis. 2021 Jun 4;223(11):1992-2000. doi: 10.1093/infdis/jiaa617. J Infect Dis. 2021. PMID: 33009576
METHODS: Serum samples donated 7-12 years after immunization at age 16-17 years with bivalent (n = 730) or quadrivalent (n = 337) HPV vaccine were retrieved from the population-based Finnish Maternity Cohort biobank. Serum antibody levels against HPV types 6, …
METHODS: Serum samples donated 7-12 years after immunization at age 16-17 years with bivalent (n = 730) or quadrivalent (n = 337) HPV vaccin …
Associations Between Maternal Antenatal Corticosteroid Treatment and Mental and Behavioral Disorders in Children.
Räikkönen K, Gissler M, Kajantie E. Räikkönen K, et al. JAMA. 2020 May 19;323(19):1924-1933. doi: 10.1001/jama.2020.3937. JAMA. 2020. PMID: 32427304 Free PMC article.
IMPORTANCE: Maternal antenatal corticosteroid treatment is standard care to accelerate fetal maturation when birth before 34 weeks is imminent. ...These findings may help inform decisions about maternal antenatal corticosteroid treatment....
IMPORTANCE: Maternal antenatal corticosteroid treatment is standard care to accelerate fetal maturation when birth before 34 weeks is …
Epstein-barr virus and multiple sclerosis risk in the finnish maternity cohort.
Munger KL, Hongell K, Cortese M, Åivo J, Soilu-Hänninen M, Surcel HM, Ascherio A. Munger KL, et al. Ann Neurol. 2019 Sep;86(3):436-442. doi: 10.1002/ana.25532. Epub 2019 Jul 3. Ann Neurol. 2019. PMID: 31226219 Free PMC article.
OBJECTIVE: To determine whether maternal Epstein-Barr virus (EBV) IgG antibody levels are associated with risk of multiple sclerosis (MS) in the offspring. METHODS: We conducted a prospective nested case-control study in the Finnish Maternity Cohort (F …
OBJECTIVE: To determine whether maternal Epstein-Barr virus (EBV) IgG antibody levels are associated with risk of multiple sclerosis …
The MATEX cohort - a Finnish population register birth cohort to study health effects of prenatal exposures.
Rumrich IK, Vähäkangas K, Viluksela M, Gissler M, Surcel HM, de Ruyter H, Jokinen J, Hänninen O. Rumrich IK, et al. BMC Public Health. 2017 Nov 7;17(1):871. doi: 10.1186/s12889-017-4881-8. BMC Public Health. 2017. PMID: 29115964 Free PMC article.
METHODS/DESIGN: The MATEX cohort is a fully register-based cohort identified from the Finnish Medical Birth Register (MBR) (1987-2015). Information from the MBR will be linked with other Finnish health registers and the population register to link the …
METHODS/DESIGN: The MATEX cohort is a fully register-based cohort identified from the Finnish Medical Birth Register (M …
Long-term Antibody Response to Human Papillomavirus Vaccines: Up to 12 Years of Follow-up in the Finnish Maternity Cohort.
Artemchuk H, Eriksson T, Poljak M, Surcel HM, Dillner J, Lehtinen M, Faust H. Artemchuk H, et al. J Infect Dis. 2019 Jan 29;219(4):582-589. doi: 10.1093/infdis/jiy545. J Infect Dis. 2019. PMID: 30239832
Linkage with the Finnish Maternity Cohort found that they donated >2500 serum samples up to 12 years later. Sera of 337 (38.6%) Gardasil and 730 (30.3%) Cervarix vaccine recipients were retrieved from the Finnish Maternity Cohort bioba …
Linkage with the Finnish Maternity Cohort found that they donated >2500 serum samples up to 12 years later. Sera of …
Cohort profile: Finnish Health and Early Life Microbiota (HELMi) longitudinal birth cohort.
Korpela K, Dikareva E, Hanski E, Kolho KL, de Vos WM, Salonen A. Korpela K, et al. BMJ Open. 2019 Jun 27;9(6):e028500. doi: 10.1136/bmjopen-2018-028500. BMJ Open. 2019. PMID: 31253623 Free PMC article.
Infant's DNA sample, mother's breast milk sample and both parent's spot faecal samples have been collected. FINDINGS TO DATE: The mean age of the mothers was 32.8 (SD 4.1) and fathers/coparents 34.8 (5.3) years at the time of enrolment. ...
Infant's DNA sample, mother's breast milk sample and both parent's spot faecal samples have been collected. FINDINGS TO …
Cohort profile: the Finnish Genetics of Pre-eclampsia Consortium (FINNPEC).
Jääskeläinen T, Heinonen S, Kajantie E, Kere J, Kivinen K, Pouta A, Laivuori H; FINNPEC Study Group. Jääskeläinen T, et al. BMJ Open. 2016 Nov 10;6(11):e013148. doi: 10.1136/bmjopen-2016-013148. BMJ Open. 2016. PMID: 28067621 Free PMC article.
Until now, research has encompassed studies on candidate genes, Sanger and next-generation sequencing, and various studies on the placenta. FINNPEC has also participated in the InterPregGen study, which is the largest investigation on maternal and fetal genet …
Until now, research has encompassed studies on candidate genes, Sanger and next-generation sequencing, and various studies on …
25-Hydroxyvitamin D deficiency and risk of MS among women in the Finnish Maternity Cohort.
Munger KL, Hongell K, Åivo J, Soilu-Hänninen M, Surcel HM, Ascherio A. Munger KL, et al. Neurology. 2017 Oct 10;89(15):1578-1583. doi: 10.1212/WNL.0000000000004489. Epub 2017 Sep 13. Neurology. 2017. PMID: 28904091 Free PMC article.
METHODS: We conducted a prospective nested case-control study among women in the Finnish Maternity Cohort (FMC). The FMC had 1.8 million stored serum samples taken during the pregnancies of over 800,000 women at the time of this study. ...
METHODS: We conducted a prospective nested case-control study among women in the Finnish Maternity Cohort (FMC). The FM …
Human Chorionic Gonadotropin Does Not Correlate with Risk for Maternal Breast Cancer: Results from the Finnish Maternity Cohort.
Fortner RT, Schock H, Kaaks R, Lehtinen M, Pukkala E, Lakso HÅ, Tanner M, Kallio R, Joensuu H, Korpela J, Toriola AT, Hallmans G, Grankvist K, Zeleniuch-Jacquotte A, Toniolo P, Lundin E, Surcel HM. Fortner RT, et al. Cancer Res. 2017 Jan 1;77(1):134-141. doi: 10.1158/0008-5472.CAN-16-1524. Epub 2016 Oct 26. Cancer Res. 2017. PMID: 27784743 Free PMC article.
We conducted a nested case-control study with 1,191 cases and 2,257 controls (matched on age and date at blood collection) in the Finnish Maternity Cohort, a cohort with serum samples from 98% of pregnancies registered in Finland since 1983. This study …
We conducted a nested case-control study with 1,191 cases and 2,257 controls (matched on age and date at blood collection) in the Finnish
575 results